Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/19070
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIlango, R-
dc.contributor.authorKavimani, S-
dc.contributor.authorJaykar, B-
dc.contributor.authorUmamaheshwari, G-
dc.date.accessioned2013-06-14T09:05:45Z-
dc.date.available2013-06-14T09:05:45Z-
dc.date.issued1999-05-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/19070-
dc.description505-508en_US
dc.description.abstractAn attempt has been made to study the release retardant behaviour of chitosan in ibuprofen tablets. Three different ibuprofen tablets were prepared by using 1, 3 and 5% chitosan paste. In vitro evaluations were carried out by using dissolution testing apparatus U.S.P (XXI). The dissolution pattern indicated the role of chitosan in sustained release. Bioavailability studies in male beagle dogs clearly showed the sustained nature of release from chitosan based ibuprofen tablet as compared to conventional ibuprofen marketed formulation. Potential use of chitosan as a new matrix forming material for sustained release preparation has been examined. Chitosan, a natural polysaccharide, has structural characteristics similar to glycosamino glycons. Chitosan has been shown to be non-toxic and biodegradable. It is inexpensive and has been explored in the present investigation as a release retarding agent in ibuprofen tablets.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.37(05) [May 1999]en_US
dc.titleDissolution studies on tablets of ibuprofen using chitosanen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.37(05) [May 1999]

Files in This Item:
File Description SizeFormat 
IJEB 37(5) 505-508.pdf690.79 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.